High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular hemorrhage
(2006) In Clinical Chemistry 52(5). p.819-826- Abstract
- Background: Intrauterine growth restriction (IUGR) is associated with perinatal mortality and with neurologic damage from intraventricular hemorrhage (IVH). We investigated whether S100B, a neural protein found in high concentrations after cell injury in the nervous system, is increased in serum of women whose pregnancies are complicated by IUGR and whose newborns develop IVH. We also explored the prognostic accuracy of maternal serum S100B for IVH in the newborn. Methods: We conducted a case-control study of 106 pregnancies complicated by IUGR, including a subgroup (n = 26) who developed IVH after birth, and 212 unaffected pregnancies matched for gestational age. Ultrasound examination, Doppler velocimetry patterns (in the utero-placental... (More)
- Background: Intrauterine growth restriction (IUGR) is associated with perinatal mortality and with neurologic damage from intraventricular hemorrhage (IVH). We investigated whether S100B, a neural protein found in high concentrations after cell injury in the nervous system, is increased in serum of women whose pregnancies are complicated by IUGR and whose newborns develop IVH. We also explored the prognostic accuracy of maternal serum S100B for IVH in the newborn. Methods: We conducted a case-control study of 106 pregnancies complicated by IUGR, including a subgroup (n = 26) who developed IVH after birth, and 212 unaffected pregnancies matched for gestational age. Ultrasound examination, Doppler velocimetry patterns (in the utero-placental vessels and middle cerebral artery), and maternal blood collection were performed before birth; cerebral ultrasound and neurologic examinations were performed after birth. Results: S100B was higher (P < 0.001) in IUGR pregnancies complicated by IVH than in those that were not and in controls. At a cutoff of 0.72 mu g/L, sensitivity was 100% [95% confidence interval (95% CI), 87%-100%] and specificity was 99.3% (97.5%-99.9%) for prediction of IVH (area under the ROC curve, 0.999). The prevalence of IVH was 8.2% in the whole study population, 93% (95% CI, 83.6%-100%) in those with maternal S100B > 0.72 mu g/L, and 0% (0%-2.5%) in those with maternal S100B < 0.72 mu g/L. Conclusion: For prediction of IVH, measurements of maternal S100B may be useful at times before clinical, laboratory, and ultrasound patterns can identify risk of IVH. (c) 2006 American Association for Clinical Chemistry. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7856209
- author
- publishing date
- 2006
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Clinical Chemistry
- volume
- 52
- issue
- 5
- pages
- 819 - 826
- publisher
- American Association for Clinical Chemistry
- external identifiers
-
- wos:000237339600006
- scopus:33646370239
- ISSN
- 0009-9147
- DOI
- 10.1373/clinchem.2005.060665
- language
- English
- LU publication?
- no
- id
- 4c99cd3c-ffac-41a0-9c0d-4e17744a722b (old id 7856209)
- date added to LUP
- 2016-04-01 11:41:08
- date last changed
- 2022-04-20 20:19:32
@article{4c99cd3c-ffac-41a0-9c0d-4e17744a722b, abstract = {{Background: Intrauterine growth restriction (IUGR) is associated with perinatal mortality and with neurologic damage from intraventricular hemorrhage (IVH). We investigated whether S100B, a neural protein found in high concentrations after cell injury in the nervous system, is increased in serum of women whose pregnancies are complicated by IUGR and whose newborns develop IVH. We also explored the prognostic accuracy of maternal serum S100B for IVH in the newborn. Methods: We conducted a case-control study of 106 pregnancies complicated by IUGR, including a subgroup (n = 26) who developed IVH after birth, and 212 unaffected pregnancies matched for gestational age. Ultrasound examination, Doppler velocimetry patterns (in the utero-placental vessels and middle cerebral artery), and maternal blood collection were performed before birth; cerebral ultrasound and neurologic examinations were performed after birth. Results: S100B was higher (P < 0.001) in IUGR pregnancies complicated by IVH than in those that were not and in controls. At a cutoff of 0.72 mu g/L, sensitivity was 100% [95% confidence interval (95% CI), 87%-100%] and specificity was 99.3% (97.5%-99.9%) for prediction of IVH (area under the ROC curve, 0.999). The prevalence of IVH was 8.2% in the whole study population, 93% (95% CI, 83.6%-100%) in those with maternal S100B > 0.72 mu g/L, and 0% (0%-2.5%) in those with maternal S100B < 0.72 mu g/L. Conclusion: For prediction of IVH, measurements of maternal S100B may be useful at times before clinical, laboratory, and ultrasound patterns can identify risk of IVH. (c) 2006 American Association for Clinical Chemistry.}}, author = {{Gazzolo, D and Marinoni, E and Di Iorio, R and Lituania, M and Marras, M and Bruschettini, Matteo and Bruschettini, P and Frulio, R and Michetti, F and Petraglia, F and Florio, P}}, issn = {{0009-9147}}, language = {{eng}}, number = {{5}}, pages = {{819--826}}, publisher = {{American Association for Clinical Chemistry}}, series = {{Clinical Chemistry}}, title = {{High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular hemorrhage}}, url = {{http://dx.doi.org/10.1373/clinchem.2005.060665}}, doi = {{10.1373/clinchem.2005.060665}}, volume = {{52}}, year = {{2006}}, }